Jexone S 250mg/125mg Injection
Marketer
Jes Pharmacia Private Limited
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Jexone S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus curbing infection spread. Administration must be under a doctor's direct supervision; strict adherence to the prescribed schedule is crucial. Complete the full treatment course, even with symptom improvement, as premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Inform your physician of all concurrent medications, and pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and ample hydration support recovery. Your doctor may order lab tests to monitor the treatment's effects.
Uses of Jexone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Jexone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Jexone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Jexone S 250mg/125mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Jexone S 250mg/125mg Injection works:
Jexone S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-action approach to combat bacterial infection. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to proliferate. The inclusion of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Jexone S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Jexone S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administration of Jexone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Jexone S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Operation of vehicles is prohibited while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Jexone S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Administering Jexone S 250mg/125mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Jexone S 250mg/125mg Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Jexone S 250mg/125mg Injection :
Should you forget a scheduled dose of Jexone S 250mg/125mg Injection, seek medical advice.
Facts to Know About Jexone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently